Chagas Disease: Independent Risk Factor for Stroke
Paixao et al.
Stroke 2009;40:3691-3694.
ABSTRACT
| FULL TEXT
Left Atrial Appendage Occlusion Eliminates the Need for Warfarin
Holmes and Schwartz
Circulation 2009;120:1919-1926.
FULL TEXT
Pharmacological and Electrical Conversion of Atrial Fibrillation to Sinus Rhythm Is Worth the Effort
Anter and Callans
Circulation 2009;120:1436-1443.
FULL TEXT
Dronedarone
Patel et al.
Circulation 2009;120:636-644.
ABSTRACT
| FULL TEXT
Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The ATRIA Study
Singer et al.
Circ Cardiovasc Qual Outcomes 2009;2:297-304.
ABSTRACT
| FULL TEXT
Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications
Schmitt et al.
Eur Heart J 2009;30:1038-1045.
ABSTRACT
| FULL TEXT
Ethnic Distribution of ECG Predictors of Atrial Fibrillation and Its Impact on Understanding the Ethnic Distribution of Ischemic Stroke in the Atherosclerosis Risk in Communities (ARIC) Study
Soliman et al.
Stroke 2009;40:1204-1211.
ABSTRACT
| FULL TEXT
Effects of alcohol on atrial fibrillation: myths and truths
Balbao et al.
Ther Adv Cardiovasc Dis 2009;3:53-63.
ABSTRACT
Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation
Friberg et al.
Eur Heart J 2009;0:ehn599v1-9.
ABSTRACT
| FULL TEXT
Effect of Surgery for Atrial Fibrillation Associated With Mitral Valve Disease
Fukunaga et al.
Ann. Thorac. Surg. 2008;86:1212-1217.
ABSTRACT
| FULL TEXT
Racial/Ethnic Differences in Ischemic Stroke Rates and the Efficacy of Warfarin Among Patients With Atrial Fibrillation
Shen et al.
Stroke 2008;39:2736-2743.
ABSTRACT
| FULL TEXT
Controversies in ablation of atrial fibrillation
Aliot and Ruskin
Eur Heart J Suppl 2008;10:H32-H54.
ABSTRACT
| FULL TEXT
The Genetic Architecture of Intracerebral Hemorrhage
Rost et al.
Stroke 2008;39:2166-2173.
ABSTRACT
| FULL TEXT
Strain rate imaging for functional quantification of the left atrium: atrial deformation predicts the maintenance of sinus rhythm after catheter ablation of atrial fibrillation
Schneider et al.
Eur Heart J 2008;29:1397-1409.
ABSTRACT
| FULL TEXT
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Singer et al.
Chest 2008;133:546S-592S.
ABSTRACT
| FULL TEXT
Pre-transplant predictors of cerebrovascular events after kidney transplantation
Aull-Watschinger et al.
Nephrol Dial Transplant 2008;23:1429-1435.
ABSTRACT
| FULL TEXT
Atrial fibrillation subtypes, risk of stroke, and antithrombotic therapy
Stramba-Badiale
Eur Heart J 2008;29:840-842.
FULL TEXT
Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers
Hansen et al.
Europace 2008;10:395-402.
ABSTRACT
| FULL TEXT
Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial Fibrillation
Fang et al.
J Am Coll Cardiol 2008;51:810-815.
ABSTRACT
| FULL TEXT
Serial Electrocardiographic Assessments Significantly Improve Detection of Atrial Fibrillation 2.6-Fold in Patients With Acute Stroke
Douen et al.
Stroke 2008;39:480-482.
ABSTRACT
| FULL TEXT
Surgical Treatment of Atrial Fibrillation
Voeller et al.
Card Surg Adult 2008;3:1375-1394.
FULL TEXT
Quality of Clinical Documentation and Anticoagulation Control in Patients With Chronic Nonvalvular Atrial Fibrillation in Routine Medical Care
Ansell et al.
American Journal of Medical Quality 2007;22:327-333.
ABSTRACT
Primary systemic amyloidosis with ischemic stroke as a presenting complication
Zubkov et al.
Neurology 2007;69:1136-1141.
ABSTRACT
| FULL TEXT
Age and follow-up time affect the prognostic value of the ECG and conventional cardiovascular risk factors for stroke in adult men
Strom Moller et al.
J. Epidemiol. Community Health 2007;61:704-712.
ABSTRACT
| FULL TEXT
Preoperative left atrial volume index is a predictor of successful sinus rhythm restoration and maintenance after the maze operation
Kim et al.
J. Thorac. Cardiovasc. Surg. 2007;134:448-453.
ABSTRACT
| FULL TEXT
Atrial fibrillatory rate and risk of left atrial thrombus in atrial fibrillation
Bollmann et al.
Europace 2007;9:621-626.
ABSTRACT
| FULL TEXT
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.
Calkins et al.
Europace 2007;9:335-379.
FULL TEXT
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J Suppl 2007;9:C3-C74.
FULL TEXT
Usefulness of Cardiovascular Investigations in Stroke Management: Clinical Relevance and Economic Implications
Douen et al.
Stroke 2007;38:1956-1958.
ABSTRACT
| FULL TEXT
Anticoagulants in heart disease: current status and perspectives
De Caterina et al.
Eur Heart J 2007;0:ehl492v1-34.
FULL TEXT
Elevated Platelet Microparticle Levels in Nonvalvular Atrial Fibrillation: Relationship to P-Selectin and Antithrombotic Therapy
Choudhury et al.
Chest 2007;131:809-815.
ABSTRACT
| FULL TEXT
A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)
Rash et al.
Age Ageing 2007;36:151-156.
ABSTRACT
| FULL TEXT
Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation
Morrison et al.
Age Ageing 2007;36:117-119.
FULL TEXT
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J 2007;28:88-136.
FULL TEXT
Impact of Maze and Concomitant Mitral Valve Surgery on Clinical Outcomes
Wong and Mak
Ann. Thorac. Surg. 2006;82:1938-1947.
ABSTRACT
| FULL TEXT
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Writing Committee Members et al.
Europace 2006;8:651-745.
FULL TEXT
Anticoagulation in patients with heart failure: who, when, and why?
Nair et al.
Eur Heart J Suppl 2006;8:E32-E38.
ABSTRACT
| FULL TEXT
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
J Am Coll Cardiol 2006;48:e149-e246.
FULL TEXT
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
Circulation 2006;114:e257-e354.
FULL TEXT
Stroke prophylaxis in atrial fibrillation: who gets it and who does not?: Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)
Friberg et al.
Eur Heart J 2006;27:1954-1964.
ABSTRACT
| FULL TEXT
Left Ventricular Systolic Dysfunction and the Risk of Ischemic Stroke in a Multiethnic Population
Hays et al.
Stroke 2006;37:1715-1719.
ABSTRACT
| FULL TEXT
Does Celecoxib Potentiate the Anticoagulant Effect of Warfarin? A Randomized, Double-Blind, Controlled Trial
Dentali et al.
The Annals of Pharmacotherapy 2006;40:1241-1247.
ABSTRACT
| FULL TEXT
Epidemiology of Aphasia Attributable to First Ischemic Stroke: Incidence, Severity, Fluency, Etiology, and Thrombolysis
Engelter et al.
Stroke 2006;37:1379-1384.
ABSTRACT
| FULL TEXT
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
Sacco et al.
Circulation 2006;113:e409-e449.
ABSTRACT
| FULL TEXT
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
Sacco et al.
Stroke 2006;37:577-617.
ABSTRACT
| FULL TEXT
Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis
Choudhry et al.
BMJ 2006;332:141-145.
ABSTRACT
| FULL TEXT
Genomics and Cardiac Arrhythmias
Roberts
J Am Coll Cardiol 2006;47:9-21.
ABSTRACT
| FULL TEXT
Four years experience of a nurse-led elective cardioversion service within a district general hospital setting.
Shelton et al.
Europace 2006;8:81-85.
ABSTRACT
| FULL TEXT
Atrial fibrillation management: a prospective survey in ESC Member Countries: The Euro Heart Survey on Atrial Fibrillation
Nieuwlaat et al.
Eur Heart J 2005;26:2422-2434.
ABSTRACT
| FULL TEXT
Hospitalized Patients With Atrial Fibrillation and a High Risk of Stroke Are Not Being Provided With Adequate Anticoagulation
Waldo et al.
J Am Coll Cardiol 2005;46:1729-1736.
ABSTRACT
| FULL TEXT
Time Trends of Ischemic Stroke Incidence and Mortality in Patients Diagnosed With First Atrial Fibrillation in 1980 to 2000: Report of a Community-Based Study
Miyasaka et al.
Stroke 2005;36:2362-2366.
ABSTRACT
| FULL TEXT
Ablation of Atrial Fibrillation Using Microwave Energy - Early Experience
Kabbani et al.
Asian Cardiovasc. Thorac. Ann. 2005;13:247-250.
ABSTRACT
| FULL TEXT
Antithrombotic Therapy Practices in US Hospitals in an Era of Practice Guidelines
Tapson et al.
Arch Intern Med 2005;165:1458-1464.
ABSTRACT
| FULL TEXT
Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation
Demircan et al.
Emerg. Med. J. 2005;22:411-414.
ABSTRACT
| FULL TEXT
Occurrence and Characteristics of Stroke Events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) Study
Sherman et al.
Arch Intern Med 2005;165:1185-1191.
ABSTRACT
| FULL TEXT
Atrial fibrillation as a predictive factor for severe stroke and early death in 15 831 patients with acute ischaemic stroke
Kimura et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:679-683.
ABSTRACT
| FULL TEXT
Indication for antithrombotic therapy for atrial fibrillation: reconciling the guidelines with clinical practice
Emmerich et al.
Eur Heart J Suppl 2005;7:C28-C33.
ABSTRACT
| FULL TEXT
Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation
O'Brien and Gage
JAMA 2005;293:699-706.
ABSTRACT
| FULL TEXT
Ximelagatran--Promises and Concerns
Gurewich
JAMA 2005;293:736-739.
FULL TEXT
Effects of False-Positive Prostate Cancer Screening Results on Subsequent Prostate Cancer Screening Behavior
Ford et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:190-194.
ABSTRACT
| FULL TEXT
Emerging Role of Direct Thrombin Inhibitors in Nonvalvular Atrial Fibrillation: Potential and Peril
Kim and Arora
J CARDIOVASC PHARMACOL THER 2005;10:11-21.
ABSTRACT
Anticoagulation in atrial fibrillation and flutter
Scholten et al.
Europace 2005;7:492-499.
ABSTRACT
| FULL TEXT
A Pharmacokinetic Study of the Combined Administration of Amiodarone and Ximelagatran, an Oral Direct Thrombin Inhibitor
Teng et al.
J Clin Pharmacol 2004;44:1063-1071.
ABSTRACT
| FULL TEXT
Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Singer et al.
Chest 2004;126:429S-456S.
ABSTRACT
| FULL TEXT
Role of oral anticoagulation in management of atrial fibrillation
Crystal and Connolly
Heart 2004;90:813-817.
FULL TEXT
Statins for the prevention of cerebrovascular disease: the rationale for robust intervention
Welch
Eur Heart J Suppl 2004;6:C34-C42.
ABSTRACT
| FULL TEXT
The Increasing Need for Anticoagulant Therapy to Prevent Stroke in Patients With Atrial Fibrillation
Ezekowitz and Falk
Mayo Clin Proc. 2004;79:904-913.
ABSTRACT
Recent trials in atrial fibrillation: lessons learned beyond rate and rhythm
Bode
Eur Heart J Suppl 2004;6:B15-B19.
ABSTRACT
| FULL TEXT
Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation
Rockson and Albers
J Am Coll Cardiol 2004;43:929-935.
ABSTRACT
| FULL TEXT
Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography
McNamara et al.
ANN INTERN MED 2003;139:1018-1033.
ABSTRACT
| FULL TEXT
The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures
Prasad et al.
J. Thorac. Cardiovasc. Surg. 2003;126:1822-1827.
ABSTRACT
| FULL TEXT
Asymptomatic mitral valve incompetence: is there evidence for surgery?
Shuhaiber
J. Thorac. Cardiovasc. Surg. 2003;126:2117-2118.
FULL TEXT
A 60-Year-Old Woman With Atrial Fibrillation
Singer
JAMA 2003;290:2182-2189.
FULL TEXT
Dronedarone for prevention of atrial fibrillation: A dose-ranging study
Touboul et al.
Eur Heart J 2003;24:1481-1487.
ABSTRACT
| FULL TEXT
Ximelagatran versus warfarin forstroke prevention in patientswith nonvalvular atrial fibrillation: SPORTIF ii: a dose-guiding, tolerability, and safety study
Petersen et al.
J Am Coll Cardiol 2003;41:1445-1451.
ABSTRACT
| FULL TEXT
Clinical histopathology and ultrastructural analysis of myocardium following microwave energy ablation
Manasse et al.
Eur. J. Cardiothorac. Surg. 2003;23:573-577.
ABSTRACT
| FULL TEXT
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)
Glotzer et al.
Circulation 2003;107:1614-1619.
ABSTRACT
| FULL TEXT
Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?
Rutten et al.
Fam Pract 2003;20:16-21.
ABSTRACT
| FULL TEXT
The underutilization of cardiacmedications of proven benefit, 1990 to 2002
Stafford and Radley
J Am Coll Cardiol 2003;41:56-61.
ABSTRACT
| FULL TEXT
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
The Atrial Fibrillation Follow-up Investigation of
NEJM 2002;347:1825-1833.
ABSTRACT
| FULL TEXT
New Evidence for Stroke Prevention: Scientific Review
Straus et al.
JAMA 2002;288:1388-1395.
ABSTRACT
| FULL TEXT
UKPDS 60: Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine
Kothari et al.
Stroke 2002;33:1776-1781.
ABSTRACT
| FULL TEXT
Prevalence and Quality of Warfarin Use for Patients With Atrial Fibrillation in the Long-term Care Setting
McCormick et al.
Arch Intern Med 2001;161:2458-2463.
ABSTRACT
| FULL TEXT
Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke: The German Stroke Data Bank
Grau et al.
Stroke 2001;32:2559-2566.
ABSTRACT
| FULL TEXT
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster et al.
Circulation 2001;104:2118-2150.
FULL TEXT
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur Heart J 2001;22:1852-1923.
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster et al.
J Am Coll Cardiol 2001;38:1231-1265.
FULL TEXT
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster et al.
J Am Coll Cardiol 2001;38:1266-1266.
FULL TEXT
Prothrombotic markers in atrial fibrillation: what is new?
Al-Saady and Sopher
Eur Heart J 2001;22:1635-1639.
